US Federal: No PFAS in Cosmetics Act Introduced

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Jennifer Porter, BA Psychology, MBA – President & CEO

Having started at Focal Point Research in 2011, Jenn has been fully engaged in the company and since day one, has leveraged her MBA and interest in the regulated products industries to grow her passion for the business and services offered.

Jenn has excelled at building on initial conversations with a variety of companies from all industries seeking regulatory and quality assurance services. She has developed strong relationships with each client, offering each one a unique opportunity to have the Focal Point Research team help them develop successful strategies and bring products to market, while ensuring their compliance needs are being fulfilled.

Jenn has not only been a leader internally, but a key contact for all clients and in 2021, Jenn was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

Jennifer balances her career by honouring her wanderlust, spending her leisure time golfing, and enjoying the outdoors with her loving dog.

A bipartisan group of US representatives has introduced HR 9594, the No PFAS in Cosmetics Act, which would amend the Federal Food, Drug, and Cosmetic Act to ban intentionally added PFAS in cosmetics. The bill defines intentionally added PFAS broadly to include PFAS deliberately added to ingredients, raw materials, products, or packaging for a functional or technical purpose, as well as intentional breakdown products. If enacted, the proposal prohibition would apply beginning January 1,2027, with FDA required to implement the ban within 270 days of enactment. The bill would also repeal the relevant PFAS provision under MoCRA.

The legislation is not currently expected to advance in Congress, but its introduction reflects continued federal scrutiny of PFAS in cosmetics. Companies should continue monitoring federal and state PFAS developments and review formulations, raw materials and packaging for intentionally added PFAS.

For further updates, do reach out to us.

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

US Federal: No PFAS in Cosmetics Act Introduced

Recent Posts

Recent Comments

Archives

Categories